期刊文献+

维拉帕米抗肝缺血再灌注损伤作用的实验研究 被引量:5

Experimental study on verapamil in treating hepatic ischemia and reperfusion injury.
暂未订购
导出
摘要 目的 探讨维拉帕米 (VP)对家兔肝缺血再灌注损伤的保护作用。方法 制备家兔肝缺血再灌注损伤模型 ,观察VP对血谷丙转氨酶 (GPT)、谷草转氨酶 (GOT)和血、肝组织黄嘌呤氧化酶 (XO)活性、丙二醛 (MDA)及肝细胞形态学变化的影响。结果 肝缺血再灌注期间 ,GPT、GOT、XO活性及MDA含量均明显升高 (P <0 0 5和P <0 0 1) ,肝细胞肿胀、空泡变性 ,线粒体、内质网明显肿胀 ;缺血前使用VP可明显减轻上述指标的异常变化 ,肝细胞形态学异常变化显著减轻。结论 缺血前使用VP具有良好的保护兔缺血再灌注损伤肝脏的作用。 Objective To explore the protective effect of verapamil (VP)in treating hepatic ischemia and reperfusion injury(HIRI).Methods Using a HIRI model in 30 rabbits,the different effects of VP on several parameters which included glutamate pyruvate transaminase(GPT)、glutamate oxaloacetate transminase(GOT) activites in the plasma and xanthine oxidase(XO) activities and malondialdehyde(MDA) contents in the plasma and liver tissue as well as hepatocellular changes morhologically were observed during HIRI.Results GPT、GOT and XO activities and MDA contents all increased very significantly( P <0 01),and there were obviously abnormal changes of liver cells morphologically during HIRI;VP adminisrered before ischemia,but not after ischemia,could obviously ameliorate the unnormal changes of parameters as above( P <0 05 and P <0 01),meanwhile unnormal changes of liver cells morphologically were remarkably alleviated.Conclusion VP administered before ischemia could effectively protect the liver frorm ischemia and reperfusion injury. [
出处 《中国急救医学》 CAS CSCD 北大核心 1999年第10期592-594,共3页 Chinese Journal of Critical Care Medicine
基金 温州医学院科研基金
关键词 维拉帕米 再灌注损伤 肝缺血 家兔 Verapamil Liver Ischemia and reperfusion injury Xanthine oxidase
  • 相关文献

参考文献2

二级参考文献5

共引文献18

同被引文献47

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部